Case report A 67 year old man of Indian descent presented with a three month history of low back pain. Physical examination was unremarkable. Plain films of the lumbar spine revealed a lytic lesion in the vertebral body of L3 associated with end plate collapse; lateral views showed an abnormal soft tissue mass anterior to the same vertebral body. A skeletal survey identified multiple lucent areas in the skull vault but no additional lytic lesions were seen elsewhere. The diagnosis of multiple myeloma was confirmed by the following investigations: electrophoresis revealed an IgGX paraprotein (quantitated at 50 gil) in the serum and free X light chains in the urine; a bone marrow aspirate contained 27% myeloma cells in the form of well differentiated plasma cells.
After receiving local radiotherapy to the lumbar spine the patient was given melphalan (10 mg/day for seven days) and prednisolone (40 mg/day for seven days), repeated at monthly intervals. The plateau phase was reached after 12 courses of the aforementioned chemotherapy (paraprotein concentration 3 g/l) and treatment was discontinued.
Two months later the patient presented with central abdominal discomfort. Physical examination yielded normal results. An abdominal ultrasound scan showed an hypoechoic mass measuring 6 cm in diameter and situated anteriorly to the lumbar spine; normal kidneys and pancreas were identified.
Plain films confirmed that this was the same soft tissue mass identified at presentation and implied the mass represented soft tissue extension of myeloma. After four weeks of clinical observation the abdominal mass had become palpable and the serum paraprotein had risen to 13 g/l. The patient was again given melphalan (10 mg/day for five days) and prednisolone (40 mg/day for five days) and local radiotherapy to the abdominal mass. The mass became impalpable and after four further courses of chemotherapy the serum paraprotein had fallen to 4 g/l.
Six weeks after completion of the fifth course of melphalan and prednisolone the patient re-presented with abdominal pain and a mass was palpable in the right hand side of the abdomen. Investigations of note were as follows: haemoglobin concentration 88 g/l; white cell count 1-9 x 109/1 (differential of neutrophils 1-3 x 109/l, lymphocytes 0*4 x 109/l, monocytes 0-2 x 109/l); platelet count of 71 x 109/1; paraprotein concentration 15 g/l; bone marrow aspirate was diluted with blood but a trephine biopsy specimen revealed a hypocellular marrow with reduced normal haemopoiesis and foci of plasma cells. Circulating plasma cells were not detected at any stage. An abdominal ultrasound scan detected a mass in the right para-aortic region and another anterior to the splenic vein; the right kidney also appeared to have been completely replaced by abnormal tumour tissue. An ultrasound guided biopsy specimen of the right renal mass was obtained, the histology of which showed sheets of plasma cells with areas of necrosis with no renal tissue identified. A computed tomogram of the abdomen was performed and relevant abnormalities are shown in fig 1 .
The serum paraprotein rose to a concentration of 19 g/l over the course of one week and the patient's general condition began to worsen. Haemopoietic recovery was delayed and the patient was given methylprednisolone (1.5 g/day for five days). He developed symptoms and signs of pulmonary sepsis and was given broad spectrum antibiotics. Unfortunately, he continued to deteriorate and died 10 days later. Two days earlier his serum paraprotein had measured 31 g/l.
Post mortem examination confirmed the presence of bronchopneumonia together with evidence of disseminated tumour of the right kidney, pancreas, porta hepatis, serosa of the transverse colon, pelvic and left perirenal fat, left-sided ribs, and left parietal pleura.
Histological examination showed a monomorphic diffuse infiltrate of plasmacytoid cells with little supporting stroma Although microscopic disease of the spleen, liver, or lymph nodes is found in up to 70% of cases at post mortem examination the presence of gross extramedullary tumour formation at other locations is less common and rarely involves more than a single site.' The pattern of spread shown in our case is very unusual for multiple myeloma. In an extensive literature search we have been able to find only one report of multiple myeloma with comparable features. Foucar described two cases of multiple myeloma that developed prominent extramedullary disease at multiple sites one and four years after initial diagnosis.3 However, one was of an IgD subtype and both cases had anaplastic features and seemed to represent a variant of multiple myeloma which resulted from a transformation of well differentiated myeloma cells to poorly differentiated immunoblastic-like cells. In contrast, the multiple extramedullary tumours in our case were all composed of cells with features of plasmacytoid differentiation.
The association between the different categories of plasma cell tumours has been the subject of much debate." Solitary myeloma of bone (SMB) usually presents as a locally painful lesion with no evidence of widespread dissemination of plasma cells in the bone marrow, although in 10-20% of cases monoclonal protein is detected. multiple myeloma.5 Although our case demonstrated radiological evidence of extraosseous spread from the vertebrae at presentation, the clinical history was short and we feel it is unlikely that the patient's disease had evolved from an SPB at that site.
The evolution of our patient's disease was unusual in that the pattern of spread following relapse from the plateau phase was similar to that seen in some cases of extramedullary plasmacytoma (EMP) in which relapse is often associated with the event of spread. The development of successive, multiple asynchronous EMP at different localisations has also been described. We thank Dr K M Hunt for allowing us to report this case.
